Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00461539 · ClinicalTrials.gov registry record · Phase 1
Reducing Health Risk Behavior and Improving Health in Adolescents With Depression
A Phase 1 study of Depression and Adolescent Health, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 1
- Development phase
- 217
- Enrollment target
- 2
- Study locations
NCT00461539: Completed Phase 1 study of Depression and Adolescent Health, sponsored by University of California, Los Angeles.
NCT00461539 is a Phase 1 study of Depression and Adolescent Health that has completed, run by University of California, Los Angeles. The registered enrollment target is 217 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (72% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00461539, a Phase 1 study of Depression and Adolescent Health, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 217 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will determine the effectiveness of a health education intervention in reducing health risk behavior and improving health in adolescents with depression.
Conditions Studied
Interventions
- OTHER Treatment as usual
- BEHAVIORAL Behavioral health intervention
Study Locations (2)
California
- University of California, Los Angeles, Semel Institute for Neuroscience and Human Behavior - Los Angeles
- Kaiser Permanente Los Angeles Medical Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 217 participants |
| Start Date | 2007-10 |
| Est. Completion | 2012-01 |
| Phase | Phase 1 |
What the finished NCT00461539 record still lists
NCT00461539 is an interventional study that assigns participants to a tested intervention. The registered 217 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (72% lower).
The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Treatment as usual is the first listed.
NCT00461539 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00461539 about?
NCT00461539 is a clinical study titled "Reducing Health Risk Behavior and Improving Health in Adolescents With Depression". This study will determine the effectiveness of a health education intervention in reducing health risk behavior and improving health in adolescents with depression.
What is the current status of trial NCT00461539?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 217 participants. The study started on 2007-10. Estimated completion is 2012-01.
What conditions does trial NCT00461539 study?
This clinical trial studies the following conditions: Depression, Adolescent Health.
What interventions are being tested in trial NCT00461539?
The interventions under investigation include: Treatment as usual (OTHER), Behavioral health intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00461539?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00461539 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00461539's enrollment target sits among peer trials
217 198th of 679 higher than 482 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 1
-
Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression
RECRUITING · Phase 1
-
Study of the Safety, Tolerability, Electrophysiological Effects and Efficacy of DMT in Humans
RECRUITING · Phase 1
-
[18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET
RECRUITING · Phase 1
-
Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05079282 · 217 participants · Phase 1
Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma
- NCT05470439 · 217 participants · NA
My Interprofessional Care Team for Adherence and Research Engagement Disparities
- NCT05981703 · 217 participants · Phase 1
A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors
- NCT06342258 · 217 participants · Phase 1
COES: Curing Order Effects on Sealants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia